Question 416 of 433
What is CAR-T, and why does it matter beyond cancer?
The short answer
It is a treatment that reprograms a patient’s own immune cells to destroy a specific target. It has cured some blood cancers, and it is now putting severe autoimmune diseases into remission.
In small studies, people with lupus and other autoimmune diseases that had resisted every treatment went into lasting, drug-free remission after CAR-T therapy. The first approval for an autoimmune condition could come in 2027. Researchers have also begun creating these cells inside the body with a simple infusion, which would avoid the complex and expensive process of removing and engineering them. That work is at the earliest stage.
Why include this in a longevity book? Because immune aging underlies much of what goes wrong late in life, and these are the first tools that reset part of the immune system.
“This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship.” From the book’s medical disclaimer. Full disclaimer
ROBUST for selected blood-cancer CAR-T indications; EARLY HUMAN STUDIES for autoimmune disease and in-vivo engineering.Evidence grade (draft mapping)ARobust human trialsBLimited or small human studiesPart 28, Q416 · Part sources
From Longevity Unmasked by Afshine Ash Emrani, MD, FACC. Medical disclaimer. This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship. Nothing here is meant to diagnose, treat, cure, or prevent any disease. Medicine is personal: a test, drug, supplement, or exercise plan that helps one person can harm another. Do not start, stop, or change any medication or treatment because of something you read in these pages. Talk with a licensed clinician who knows your history first. If you think you are having a medical emergency, call 911. The author disclaims responsibility for any loss or harm arising from use of the information in this book.